CytoMed Therapeutics’ (NASDAQ:GDTC – Get Free Report) lock-up period will end on Wednesday, October 11th. CytoMed Therapeutics had issued 2,412,369 shares in its public offering on April 14th. The total size of the offering was $9,649,476 based on an initial share price of $4.00. After the end of CytoMed Therapeutics’ lock-up period, restrictions preventing company […]
CytoMed Therapeutics’ (NASDAQ:GDTC – Get Free Report) lock-up period is set to end on Wednesday, October 11th. CytoMed Therapeutics had issued 2,412,369 shares in its initial public offering on April 14th. The total size of the offering was $9,649,476 based on an initial share price of $4.00. After the end of CytoMed Therapeutics’ lock-up period, […]
CytoMed Therapeutics’ (NASDAQ:GDTC – Get Rating) quiet period is set to expire on Wednesday, May 24th. CytoMed Therapeutics had issued 2,412,369 shares in its IPO on April 14th. The total size of the offering was $9,649,476 based on an initial share price of $4.00. During the company’s quiet period, underwriters and any insiders involved in […]